SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-007405
Filing Date
2021-05-17
Accepted
2021-05-17 16:16:00
Documents
3
Period of Report
2021-05-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210517x8k.htm 8-K 27765
2 EX-99.1 tmb-20210517xex99d1.htm EX-99.1 208088
3 GRAPHIC tmb-20210517xex99d1001.jpg GRAPHIC 2677
  Complete submission text file 0001558370-21-007405.txt   240915
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 21930842
SIC: 3845 Electromedical & Electrotherapeutic Apparatus